(IN BRIEF) The European Investment Bank (EIB) and Romania’s leading pharmaceutical manufacturer, Antibiotice, have partnered to support the production of medicines in Romania. Through a €25 million loan agreement, the EIB will finance the construction of a modern production, packaging, … Read the full press release
Posted in Banks, Business, Construction, Economy, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Pharma & Biotech, Romania, Technology
Tagged Antibiotice, European Investment Bank, Healthcare, Ioan Nani, Medicine Production, Paolo Gentiloni, partnership, Romania, sustainability, Teresa Czerwinska
(NOTIZIA IN BREVE) Antibiotice SA, uno dei principali produttori rumeni di farmaci generici, ha firmato un nuovo accordo di consulenza con la Banca europea per gli investimenti (BEI) per contribuire a sviluppare la sua capacità di sviluppare nuovi farmaci generici, … Read the full press release
Posted in Banks, Business, European Union, Financial, Investment, Pharma & Biotech, Romania
Tagged Antibiotice SA, azienda rumena, EIB, farmaci generici, Hristo Stoykov, Ioan Nani
(IN BRIEF) Antibiotice SA, a leading Romanian manufacturer of generic drugs, has signed a new advisory agreement with the European Investment Bank (EIB) to help build its capacity to develop new generic drugs, improve production processes, and strengthen its local … Read the full press release
Posted in Banks, Business, European Union, Financial, Investment, Pharma & Biotech, Romania
Tagged Antibiotice SA, EIB, generic drugs, Hristo Stoykov, Ioan Nani, Romanian company
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
